Nephrology Section, Department of General Internal Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
J Investig Med. 2011 Oct;59(7):1083-5. doi: 10.2310/JIM.0b013e31822cf86e.
Erythropoietin (EPO) is used at present in clinical practice to stimulate red cell production. However, a number of reports have emerged suggesting the presence of nonerythropoietic properties for EPO. Chief among them is its ability to confer protection against acute tissue injury. In this report, we briefly review the role of EPO in tissue protection and provide examples of tissue protection using cisplatin-induced kidney injury model. Also provided is a brief description of potential pathways through which EPO may be mediating this effect.
促红细胞生成素(EPO)目前在临床上被用于刺激红细胞生成。然而,有许多报道表明 EPO 具有非红细胞生成特性。其中最重要的是它能够提供对急性组织损伤的保护。在本报告中,我们简要回顾了 EPO 在组织保护中的作用,并提供了使用顺铂诱导的肾损伤模型进行组织保护的实例。还简要描述了 EPO 可能介导这种作用的潜在途径。